CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Umuthi Healthcare Solutions PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Umuthi Healthcare Solutions PLC
Eastcastle House
27-28 Eastcastle Street
LONDON, W1W 8DH  United Kingdom
Business Summary
Umuthi Healthcare Solutions PLC is a United Kingdom-based company that is focused on building a technology led healthcare business based in South Africa. The Company is principally focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas. The Company has four principal business segments: Supplying pharmaceuticals and other medical products to medical practitioners and dispensaries; Owning and operating medical facilities, including hospitals and clinics; Providing diagnostic solutions and facilitating medical research; and Offering medical insurance. The main operating subsidiary, Lems Pharmaceucal Limited, incorporated in South Africa, supplies prescription and other medicines to medical practitioners and health centers with onsite dispensaries in rural and non-rural areas of South Africa.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20222/28/2022Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
8062 General medical and surgical hospitals
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Shaun I.Gresse
Chief Executive Officer, Founder, Director GertViljoen

Business Names
Business Name
Lems Pharmaceucal Limited
UHS

General Information
Outstanding Shares: 101,400,000 (As of 2/28/2022)
Stock Exchange: LON


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024